Cleerly vs CureMetrix

CureMetrix's cmAngio detects and quantifies breast arterial calcification on screening mammograms, and the company says it also contextualizes the finding. It was decided as K232367 in October 2023, with V2.0 following in July 2026. The company reports an AUC of 0.98 to 0.992 and over 400 U.S. sites from its own data, and lists its cmAssist CAD as still under development in the U.S.

Cleerly works from coronary CT angiograms instead. It quantifies plaque volume, composition and stenosis, adds ischemia likelihood through Cleerly ISCHEMIA (K231335, September 2023), integrates with PowerScribe, and has Category I CPT code 75577 from January 2026.

The two read different exams, so a mammography network and a cardiac CT program rarely shop them against each other. Findings from exams a network already reads are CureMetrix's draw. Plaque numbers in a CCTA service's report are Cleerly's.